Page 140 - Read Online
P. 140

with larger numbers of patients in order to confirm our   11.  Feng JF, Huang Y, Liu JS. Combination of neutrophil lymphocyte
           preliminary observations.                              ratio and platelet lymphocyte ratio is a useful predictor of
                                                                  postoperative survival in patients with esophageal squamous cell
                                                                  carcinoma. Onco Targets Ther 2013;6:1605‑12.
           REFERENCES                                         12.  Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG,
                                                                  Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival
           1.   Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G,   in patients with cancer. Br J Cancer 2012;107:695‑9.
              Tsavachidis  S, Liang  FW, Gilbert  M, Aldape  K, Armstrong  T,   13.  Han S, Zhang C, Li Q, Dong J, Liu Y, Huang Y, Jiang T, Wu A.
              Houlston R, Hosking F, Robertson L, Xiao Y, Wiencke J, Wrensch M,   Tumour‑infiltrating CD4(+) and CD8(+) lymphocytes as predictors
              Andersson  U,  Melin  BS,  Bondy  M.  Polymorphisms  of  LIG4,   of clinical outcome in glioma. Br J Cancer 2014;110:2560‑8.
              BTBD2, HMGA2, and RTEL1 genes involved in the double‑strand   14.  Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE,
              break repair pathway predict glioblastoma survival. J Clin Oncol   Drake C, O’Dea P, Bermingham N, Keohane C, Grossman SA,
              2010;28:2467‑74.                                    Moylan EJ, O’Reilly S. The association of pre‑treatment neutrophil
           2.   Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC,   to lymphocyte ratio with overall survival in patients with glioblastoma
              Clarke SJ. The systemic inflammation‑based neutrophil‑lymphocyte   multiforme. J Neurooncol 2013;114:149‑54.
              ratio: experience in patients with cancer. Crit Rev Oncol Hematol   15.  Alexiou  GA, Vartholomatos  G, Karamoutsios  A, Batistatou  A,
              2013;88:218‑30.                                     Kyritsis AP, Voulgaris S. Circulating progenitor cells: a comparison
           3.   Yuan D, Zhu K, Li K, Yan R, Jia Y, Dang C. The preoperative   of patients with glioblastoma or meningioma. Acta Neurol Belg
              neutrophil‑lymphocyte  ratio  predicts  recurrence  and  survival   2013;113:7‑11.
              among patients undergoing R0 resections of adenocarcinomas of   16.  Alexiou GA, Zikou A, Tsiouris S, Goussia A, Kosta P, Papadopoulos A,
              the esophagogastric junction. J Surg Oncol 2014;110:333‑40.  Voulgaris S, Tsekeris P, Kyritsis AP, Fotopoulos AD, Argyropoulou MI.
           4.   Templeton AJ, McNamara MG, Šeruga B, Vera‑Badillo FE, Aneja P,   Comparison of diffusion tensor, dynamic susceptibility contrast MRI
              Ocaña  A,  Leibowitz‑Amit  R,  Sonpavde  G,  Knox  JJ,  Tran  B,   and (99m) Tc‑Tetrofosmin brain SPECT for the detection of recurrent
              Tannock IF, Amir E. Prognostic role of neutrophil‑to‑lymphocyte   high‑grade glioma. Magn Reson Imaging 2014;32:854‑9.
              ratio in solid tumors: a systematic review and meta‑analysis. J Natl   17.  Steffens S, Köhler A, Rudolph R, Eggers H, Seidel C, Janssen M,
              Cancer Inst 2014;106:dju124.                        Wegener G, Schrader M, Kuczyk MA, Schrader AJ. Validation of
           5.   Lang BH, Ng CP, Au KB, Wong KP, Wong KK, Wan KY. Does   CRP as prognostic marker for renal cell carcinoma in a large series
              preoperative neutrophil lymphocyte ratio predict risk of recurrence   of patients. BMC Cancer 2012;12:399.
              and occult central nodal metastasis in papillary thyroid carcinoma?   18.  Alexiou  GA, Goussia  A, Voulgaris  S, Fotopoulos  AD,
              World J Surg 2014;38:2605‑12.                       Fotakopoulos G, Ntoulia A, Zikou A, Tsekeris P, Argyropoulou MI,
           6.   Xue TC, Zhang L, Xie XY, Ge NL, Li LX, Zhang BH, Ye SL, Ren ZG.   Kyritsis AP. Prognostic significance of MRP5 immunohistochemical
              Prognostic significance of the neutrophil‑to‑lymphocyte ratio in   expression in glioblastoma.  Cancer Chemother Pharmacol
              primary liver cancer: a meta‑analysis. PLoS One 2014;9:e96072.  2012;69:1387‑91.
           7.   Ozdemir Y, Akin ML, Sucullu I, Balta AZ, Yucel E. Pretreatment   19.  Chaichana KL, McGirt MJ, Frazier J, Attenello F, Guerrero‑Cazares H,
              neutrophil/lymphocyte ratio as a prognostic aid in colorectal cancer.   Quinones‑Hinojosa A. Relationship of glioblastoma multiforme to
              Asian Pac J Cancer Prev 2014;15:2647‑50.            the lateral ventricles predicts survival following tumor resection.
           8.   Chang  Z, Zheng  J, Ma  Y, Zhao  J, Wang  C, Liu  Z. The   J Neurooncol 2008;89:219‑24.
              neutrophil‑to‑lymphocyte ratio as a predictor for recurrence of   20.  Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S. Relationship of
              colorectal liver metastases following radiofrequency ablation. Med   glioblastoma multiforme to the subventricular zone is associated
              Oncol 2014;31:855.                                  with survival. Neuro Oncol 2013;15:91‑6.
           9.   Xiao WK, Chen D, Li SQ, Fu SJ, Peng BG, Liang LJ. Prognostic
              significance of neutrophil‑lymphocyte ratio in hepatocellular   Cite this article as: Alexiou GA, Vartholomatos E, Zagorianakou P, Voulgaris
              carcinoma: a meta‑analysis. BMC Cancer 2014;14:117.  S. Prognostic significance of neutrophil-to-lymphocyte ratio in glioblastoma.
           10.  Williams KA, Labidi‑Galy SI, Terry KL, Vitonis AF, Welch WR,   Neuroimmunol Neuroinflammation 2014;1(3):131-4.
              Goodman A, Cramer DW. Prognostic significance and predictors   Source of Support: Nil. Conflict of Interest: No.
              of the neutrophil‑to‑lymphocyte ratio in ovarian cancer. Gynecol
              Oncol 2014;132:542‑50.                           Received: 21-07-2014; Accepted: 25-08-2014
































            134                                             Neuroimmunol Neuroinflammation | Volume 1 | Issue 3 | December 2014
   135   136   137   138   139   140   141   142   143   144   145